Overcoming methodical limits of standard RHD genotyping by next-generation sequencing

Vox Sanguinis

Volumn 100, Issue 4, 2011, Pages 381-388

  Stabentheiner, S ^a   Danzer, M ^a   Niklas, N ^a   Atzmuller S ^a   Proll J ^a   Hackl, C ^a   Polin, H ^a   Hofer, K ^a   Gabriel, C ^a  

^a Red Cross Transfusion Service of Upper Austria   (Austria)

Author keywords

Genotyping; Next generation sequencing; RHD; Sequence based typing

Indexed keywords

ARTICLE; BLOOD GROUP RH; CLONE; DNA DETERMINATION; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; GOLD STANDARD; HETEROZYGOSITY; HUMAN; INTRON; PHENOTYPE; PILOT STUDY; PRIORITY JOURNAL; PYROSEQUENCING; RHD GENE; SEQUENCE ANALYSIS; VALIDATION PROCESS;

BLOOD GROUPING AND CROSSMATCHING; FEMALE; HUMANS; MALE; POLYMORPHISM, GENETIC; RH-HR BLOOD-GROUP SYSTEM; SEQUENCE ANALYSIS, DNA;

EID: 79954551036     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01444.x     Document Type: Article

References (33)

1. Flegel WA, Wagner FF: Molecular biology of partial D and weak D: implications for blood bank practice. Clin Lab 2002; 48:53-59
2. Wagner FF, Gassner C, Muller TH, et al.: Molecular basis of weak D phenotypes. Blood 1999; 93:385-393
3. Flegel WA, von Zabern I, Wagner FF: Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009; 49:465-471
4. Westhoff CM: Molecular genotyping for RHD: what (not) to do? Transfusion 2007; 47:1337-1339
5. Westhoff CM, Sloan SR: Molecular genotyping in transfusion medicine. Clin Chem 2008; 54:1948-1950
6. Legler TJ, Maas JH, Kohler M, et al.: RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001; 11:383-388
7. Polin H, Danzer M, Hofer K, et al.: Effective molecular RHD typing strategy for blood donations. Transfusion 2007; 47:1350-1355
8. Polin H, Danzer M, Gaszner W, et al.: Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 2009; 49:676-681
9. Avent ND: Large-scale blood group genotyping: clinical implications. Br J Haematol 2009; 144:3-13
10. Quill E: Medicine. Blood-matching goes genetic. Science 2008; 319:1478-1479
11. Veldhuisen B, van der Schoot CE, de Haas M: Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009; 97:198-206
12. Hopp K, Weber K, Bellissimo D, et al.: High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010; 50:40-46
13. Margulies M, Egholm M, Altman WE, et al.: Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005; 437:376-380
14. Gabriel C, Danzer M, Hackl C, et al.: Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. Hum Immunol 2009; 70:960-964
15. Bentley G, Higuchi R, Hoglund B, et al.: High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009; 74:393-403
16. Simen BB, Simons JF, Hullsiek KH, et al.: Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis 2009; 199:693-701
17. Wheeler DA, Srinivasan M, Egholm M, et al.: The complete genome of an individual by massively parallel DNA sequencing. Nature 2008; 452:872-876
18. Thomas RK, Nickerson E, Simons JF, et al.: Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med 2006; 12:852-855
19. Voelkerding KV, Dames SA, Durtschi JD: Next-generation sequencing: from basic research to diagnostics. Clin Chem 2009; 55:641-658
20. R Development Core Team: An introduction to R. Notes on R: Programming Environment and Language for Data Analysis and Graphics. 2009
21. Singleton BK, Green CA, Avent ND, et al.: The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 2000; 95:12-18
22. Wagner FF: The Rhesus Base [database on the Internet]. Ulm, Germany: Department of Transfusion Medicine, University Hospital; 1998. available from.
23. van der Schoot CE, de Haas M, Engelfriet CP, et al.: Genotyping for red blood cell polymorphisms. Vox Sang 2009; 96:167-179
24. Gassner C, Schmarda A, Kilga-Nogler S, et al.: RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 1997; 37:1020-1026
25. Danzer M, Polin H, Stabentheiner S, et al.: Comprehensive polymorphism analysis of ABO using allele-specific separation by bead technology and subsequent sequencing. Vox Sang 2009; 98:451-454
26. Grootkerk-Tax MG, van Wintershoven JD, Ligthart PC, et al.: RHD(T201R, F223V) cluster analysis in five different ethnic groups and serologic characterization of a new Ethiopian variant DARE, the DIII type 6, and the RHD(F223V). Transfusion 2006; 46:606-615
27. Flegel WA, Gabriel C, Gassner W, et al.: RHD genotyping of blood donors may avoid anti-D immunization [abstract]. Blood 2004; 104:2706
28. Yu X, Wagner FF, Witter B, et al.: Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion 2006; 46:1343-1351
29. Muller TH, Wagner FF, Trockenbacher A, et al.: PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001; 41:45-52
30. Lin IL, Shih MC, Hsieh MH, et al.: Molecular basis of weak D in Taiwanese. Ann Hematol 2003; 82:617-620
31. Rouillac C, Le Van KC, Beolet M, et al.: Leu110Pro substitution in the RhD polypeptide is responsible for the DVII category blood group phenotype. Am J Hematol 1995; 49:87-88
32. Wagner FF, Eicher NI, Jorgensen JR, et al.: DNB: a partial D with anti-D frequent in Central Europe. Blood 2002; 100:2253-2256
33. Wagner FF, Frohmajer A, Flegel WA: RHD positive haplotypes in D negative Europeans. BMC Genet 2001; 2:10